Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05015491 · ClinicalTrials.gov registry record · NA
Effects of Online App Weight Loss Programs on Liver Health in Obese Adults
A NA study, sponsored by Noom.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT05015491: Completed NA study, sponsored by Noom.
NCT05015491 is a NA study that has completed, run by Noom. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05015491, a NA study, has completed, sponsored by Noom.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The primary objective of this trial is to assess the effects of online app weight loss programs on liver health in obese adults.
Primary Outcome
BMI
Interventions
- BEHAVIORAL Noom Healthy Weight Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2021-08-09 |
| Est. Completion | 2022-09-12 |
| Phase | NA |
What the finished NCT05015491 record still lists
NCT05015491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Noom Healthy Weight Program is the first listed.
NCT05015491 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05015491 about?
NCT05015491 is a clinical study titled "Effects of Online App Weight Loss Programs on Liver Health in Obese Adults". The primary objective of this trial is to assess the effects of online app weight loss programs on liver health in obese adults.
What is the current status of trial NCT05015491?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2021-08-09. Estimated completion is 2022-09-12.
What interventions are being tested in trial NCT05015491?
The interventions under investigation include: Noom Healthy Weight Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05015491?
This trial is sponsored by Noom, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05015491's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI